X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Pharma Industry News - 16/Sep 15:09

Moderate Hypofractionation Shows Good Safety Outcomes in Breast Cancer

MONDAY, Sept. 16, 2024 -- For patients with breast cancer, moderate hypofractionation (MHF) shows an improved safety profile, cosmesis, and quality of life compared with conventional fractionation (CF), with equivalent oncologic outcomes, according...

Articles similaires

Hypofractionation proven safer and more convenient for breast cancer treatment

news.medical.net - 13/Sep 11:26

Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects...

Hypofractionation proven safer and more convenient for breast cancer treatment

news.medical.net - 13/Sep 11:26

Giving higher doses per fraction of radiation therapy over a shorter time after breast cancer surgery significantly reduces the risk of side effects...

10-year study shows DBT outperforms 2D mammography in breast cancer detection

news.medical.net - 17/Sep 16:09

According to a new 10-year study, screening for breast cancer with digital breast tomosynthesis (DBT) increases cancer detection rates and...

Fewer, More Powerful Radiation Sessions Improve Breast Cancer Outcomes

medindia.net - 12/Sep 21:05

Shorter-course radiation therapy is a more efficient and equally effective option for breast cancer patients compared to traditional longer...

Post-treatment lifestyle choices influence long-term outcomes in breast cancer patients

news.medical.net - 17/Sep 17:24

Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer.

Sorry! Image not available at this time

Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer Patients

drugs.com - 17/Sep 21:13

TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...

Sorry! Image not available at this time

Early, Virtual Palliative Care Feasible for Advanced Lung Cancer

drugs.com - 17/Sep 15:09

TUESDAY, Sept. 17, 2024 -- The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with...

New cancer drug shows encouraging results in Phase I/II trial

news.medical.net - 14/Sep 08:17

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial...

Sorry! Image not available at this time

Perioperative Nivolumab Beneficial for Resectable NSCLC

drugs.com - 12/Sep 15:09

THURSDAY, Sept. 12, 2024 -- For patients with resectable non-small-cell lung cancer (NSCLC), perioperative nivolumab is associated with event-free...

Sorry! Image not available at this time

Psychological Illness, CVD Risk Increased for Relatives, Spouses of Cancer Patients

drugs.com - 09/Sep 16:02

MONDAY, Sept. 9, 2024 -- Cancer diagnosis is associated with an increased risk for psychological illness and cardiovascular disease among...